The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Abbott | Common | 002824100 | 16,510,500 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
Abbvie | Common | 00287Y109 | 21,385,860 | 138,000 | SH | SOLE | 138,000 | 0 | 0 | ||
Allstate | Common | 020002101 | 17,805,456 | 127,200 | SH | SOLE | 127,200 | 0 | 0 | ||
Uhaul | Common | 023586100 | 5,083,799 | 70,805 | SH | SOLE | 70,805 | 0 | 0 | ||
Uhaul B | Common | 023586506 | 37,780,494 | 536,350 | SH | SOLE | 536,350 | 0 | 0 | ||
Apple | Common | 037833100 | 6,757,803 | 35,100 | SH | SOLE | 35,100 | 0 | 0 | ||
Ashland | Common | 044209104 | 1,264,650 | 15,000 | SH | SOLE | 15,000 | 0 | 0 | ||
Avista | Common | 05379B107 | 7,201,610 | 201,500 | SH | SOLE | 201,500 | 0 | 0 | ||
Caribu Biosciences | Common | 142038108 | 1,146,000 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
CMS Energy | Common | 125896100 | 18,350,120 | 316,000 | SH | SOLE | 316,000 | 0 | 0 | ||
Acorda Theraputics | Cv 6.0% | 00484MAB2 | 2,437,500 | 5,000,000 | PRN | SOLE | 5,000,000 | 0 | 0 | ||
Accelerate Diagnostic | Cv 5.0% | 00430HAC6 | 1,910,792 | 3,133,920 | PRN | SOLE | 3,133,920 | 0 | 0 | ||
Darling Ingredients | Common | 237266101 | 6,977,600 | 140,000 | SH | SOLE | 140,000 | 0 | 0 | ||
Duke Energy | Common | 26441C204 | 19,785,485 | 203,890 | SH | SOLE | 203,890 | 0 | 0 | ||
EDAP | Common | 268311107 | 2,923,282 | 553,652 | SH | SOLE | 553,652 | 0 | 0 | ||
Fate Theraputics | Common | 31189P102 | 534,820 | 143,000 | SH | SOLE | 143,000 | 0 | 0 | ||
AT & T | Common | 00206R102 | 16,125,580 | 961,000 | SH | SOLE | 961,000 | 0 | 0 | ||
Warner Bros. Discovery | Common | 934423104 | 121,106 | 10,642 | SH | SOLE | 10,642 | 0 | 0 | ||
Nextera Energy | Common | 302571104 | 17,833,264 | 293,600 | SH | SOLE | 293,600 | 0 | 0 | ||
Kodiak Sciences | Common | 50015M109 | 1,437,920 | 473,000 | SH | SOLE | 473,000 | 0 | 0 | ||
Personalis | Common | 71535D106 | 630,000 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
908 Devices | Common | 65443P102 | 766,169 | 68,286 | SH | SOLE | 68,286 | 0 | 0 | ||
Lava Theraputics | Common | N51517105 | 1,219,561 | 771,874 | SH | SOLE | 771,874 | 0 | 0 | ||
Newmont | Common | 651639106 | 2,715,184 | 65,600 | SH | SOLE | 65,600 | 0 | 0 | ||
IGM Bioscience | Common | 449585108 | 540,150 | 65,000 | SH | SOLE | 65,000 | 0 | 0 | ||
Insteel | Common | 45774W108 | 13,149,667 | 343,423 | SH | SOLE | 343,423 | 0 | 0 | ||
Organon | Common | 68622V106 | 449,760 | 31,190 | SH | SOLE | 31,190 | 0 | 0 | ||
Mannkind | Common | 56400P706 | 710,066 | 195,073 | SH | SOLE | 195,073 | 0 | 0 | ||
Merck | Common | 589331107 | 24,060,714 | 220,700 | SH | SOLE | 220,700 | 0 | 0 | ||
Pfizer | Common | 717081103 | 7,730,115 | 268,500 | SH | SOLE | 268,500 | 0 | 0 | ||
RLI | Common | 749607107 | 266,240 | 2,000 | SH | SOLE | 2,000 | 0 | 0 | ||
Supernus | Common | 868459108 | 2,376,119 | 82,105 | SH | SOLE | 82,105 | 0 | 0 | ||
Viatris | Common | 92556V106 | 630,869 | 58,252 | SH | SOLE | 58,252 | 0 | 0 | ||
Vicor | Common | 925815102 | 1,348,200 | 30,000 | SH | SOLE | 30,000 | 0 | 0 | ||
Bausch Health | Common | 91911K102 | 5,164,880 | 644,000 | SH | SOLE | 644,000 | 0 | 0 | ||
XM Sirius | Common | 82968B103 | 3,051,401 | 557,843 | SH | SOLE | 557,843 | 0 | 0 | ||
XEL Energy | Common | 98389B100 | 18,396,630 | 293,000 | SH | SOLE | 293,000 | 0 | 0 |